Revance Therapeutics shares owned by Nebula Research & Development
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Nebula Research & Development
from 13F filings
Historical chart of Nebula Research & Development investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Nebula Research & Development
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $371k | 144k | 2.57 |
| 2024-03-31 | $860k | 175k | 4.92 |
| 2023-06-30 | $294k | 12k | 25.31 |
More positions owned by Nebula Research & Development
View all positions for Nebula Research & Development